Kochi University   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Kochi Japan (1922)

Organization Overview

First Clinical Trial
2007
NCT01434524
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Department of Dermatology, Kochi Medical School, Kochi University | Kochi Medical School | Kochi University | Kochi University Medical School

Active Ingredients

Drugs in Phase 4 Trials (2)

mirtazapine (remeron) (1 trial)

sertraline (zoloft) (1 trial)

Drugs in Phase 3 Trials (3)

gemcitabine (gemzar) (1 trial)

levocarnitine (carnitor) (1 trial)

paclitaxel (taxol) (1 trial)

Drugs in Phase 2 Trials (1)

sta-21 (1 trial)

Drugs in Other Trials (6)

aminoleban (1 trial)

glucose (1 trial)

leucine (1 trial)

l-isoleucine (1 trial)

sivelestat (1 trial)

valine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 4)

Psoriasis (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 12